Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
Titel:
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
Auteur:
Zhang, Zeda Zhou, Chuanli Li, Xiaoling Barnes, Spencer D. Deng, Su Hoover, Elizabeth Chen, Chi-Chao Lee, Young Sun Zhang, Yanxiao Wang, Choushi Metang, Lauren A. Wu, Chao Tirado, Carla Rodriguez Johnson, Nickolas A. Wongvipat, John Navrazhina, Kristina Cao, Zhen Choi, Danielle Huang, Chun-Hao Linton, Eliot Chen, Xiaoping Liang, Yupu Mason, Christopher E. de Stanchina, Elisa Abida, Wassim Lujambio, Amaia Li, Sheng Lowe, Scott W. Mendell, Joshua T. Malladi, Venkat S. Sawyers, Charles L. Mu, Ping